Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Current Deferred Revenue (2021 - 2025)

Volitionrx's Current Deferred Revenue history spans 5 years, with the latest figure at $353846.0 for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 53.85% year-over-year to $353846.0; the TTM value through Dec 2025 reached $353846.0, up 53.85%, while the annual FY2025 figure was $353846.0, 53.85% up from the prior year.
  • Current Deferred Revenue reached $353846.0 in Q4 2025 per VNRX's latest filing, roughly flat from $354000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $12.5 billion in Q4 2021 to a low of $96225.0 in Q3 2024.
  • Average Current Deferred Revenue over 5 years is $784.7 million, with a median of $291923.0 recorded in 2024.
  • Peak YoY movement for Current Deferred Revenue: plummeted 98.99% in 2024, then skyrocketed 267.89% in 2025.
  • A 5-year view of Current Deferred Revenue shows it stood at $12.5 billion in 2021, then tumbled by 99.99% to $1.0 million in 2022, then tumbled by 89.34% to $106600.0 in 2023, then skyrocketed by 115.76% to $230000.0 in 2024, then surged by 53.85% to $353846.0 in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Current Deferred Revenue are $353846.0 (Q4 2025), $354000.0 (Q3 2025), and $122441.0 (Q2 2025).